Nephros, Inc. (NEPH)

USD 1.81

(-2.16%)

Long Term Debt Summary of Nephros, Inc.

  • Nephros, Inc.'s latest annual long term debt in 2023 was 1.39 Million USD , up 96.88% from previous year.
  • Nephros, Inc.'s latest quarterly long term debt in 2024 Q2 was 1.22 Million USD , down -100.0% from previous quarter.
  • Nephros, Inc. reported annual long term debt of 706 Thousand USD in 2022, up 38.16% from previous year.
  • Nephros, Inc. reported annual long term debt of 511 Thousand USD in 2021, down -68.3% from previous year.
  • Nephros, Inc. reported quarterly long term debt of 1.3 Million USD for 2024 Q1, down -5.97% from previous quarter.
  • Nephros, Inc. reported quarterly long term debt of 469 Thousand USD for 2023 Q3, down -12.17% from previous quarter.

Annual Long Term Debt Chart of Nephros, Inc. (2023 - 2002)

Historical Annual Long Term Debt of Nephros, Inc. (2023 - 2002)

Year Long Term Debt Long Term Debt Growth
2023 1.39 Million USD 96.88%
2022 706 Thousand USD 38.16%
2021 511 Thousand USD -68.3%
2020 1.61 Million USD 6.61%
2019 1.51 Million USD 79.36%
2018 843 Thousand USD -11.64%
2017 954 Thousand USD 13.84%
2016 838 Thousand USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD -100.0%
2006 5.38 Million USD 778.07%
2005 613.72 Thousand USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%

Peer Long Term Debt Comparison of Nephros, Inc.

Name Long Term Debt Long Term Debt Difference
Akoya Biosciences, Inc. 75.25 Million USD 98.153%
AngioDynamics, Inc. 3.93 Million USD 64.712%
AtriCure, Inc. 60.59 Million USD 97.706%
Avinger, Inc. - USD -Infinity%
Azenta, Inc. 60.43 Million USD 97.7%
BioLife Solutions, Inc. 18.31 Million USD 92.409%
The Cooper Companies, Inc. 2.52 Billion USD 99.945%
Daxor Corporation 755.65 Thousand USD -83.945%
Ekso Bionics Holdings, Inc. 4.83 Million USD 71.233%
Femasys Inc. 4.25 Million USD 67.357%
GlucoTrack, Inc. 196 Thousand USD -609.184%
Harvard Bioscience, Inc. 30.7 Million USD 95.473%
Hologic, Inc. 2.49 Billion USD 99.944%
ICU Medical, Inc. 1.57 Billion USD 99.912%
Intuitive Surgical, Inc. -82.1 Million USD 101.693%
KORU Medical Systems, Inc. 3.65 Million USD 61.948%
LeMaitre Vascular, Inc. 16.62 Million USD 91.639%
Innovative Eyewear, Inc. - USD -Infinity%
Innovative Eyewear, Inc. - USD -Infinity%
Masimo Corporation 871.7 Million USD 99.841%
Microbot Medical Inc. 40 Thousand USD -3375.0%
Meihua International Medical Technologies Co., Ltd. 4592.00 USD -30170.035%
Merit Medical Systems, Inc. 823.01 Million USD 99.831%
NovoCure Limited 596.24 Million USD 99.767%
NEXGEL, Inc. 513 Thousand USD -170.955%
NEXGEL, Inc. 513 Thousand USD -170.955%
Singular Genomics Systems, Inc. 67.52 Million USD 97.941%
OraSure Technologies, Inc. 11.38 Million USD 87.794%
Pro-Dex, Inc. 7.53 Million USD 81.555%
Pulse Biosciences, Inc. 8.08 Million USD 82.81%
Predictive Oncology Inc. 2.18 Million USD 36.5%
Precision Optics Corporation, Inc. 1.93 Million USD 28.275%
QuidelOrtho Corporation 2.27 Billion USD 99.939%
Repligen Corporation 510.14 Million USD 99.728%
Sanara MedTech Inc. 9.11 Million USD 84.747%
STAAR Surgical Company 31.46 Million USD 95.583%
Sharps Technology, Inc. - USD -Infinity%
Utah Medical Products, Inc. 295 Thousand USD -371.186%
DENTSPLY SIRONA Inc. 1.79 Billion USD 99.923%
Jin Medical International Ltd. - USD -Infinity%